구조모아 (StructureMoa)항암 chemical structure spider web
방문타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Standard Therapeutic DLI (Standard Therapeutic DLI) University of Arizona·Acute Lymphoid Leukemia 16 trials |
|---|---|
Overview Program | Standard Therapeutic DLI |
Overview Company | University of Arizona |
Overview Modality | CGT |
Overview Target | Acute Lymphoid Leukemia |
Overview Indication | Acute Lymphoid Leukemia; Acute Myeloid Leukemia |
Overview Phase | PHASE_1 |
Overview Status | RECRUITING |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | Diverting loop ileostomy with antegrade colonic lavage compared with colectomy in Clostridioides difficile colitis: A decade-long propensity score-matched analysis.. Fulminant Clostridioides difficile colitis (CDC) carries high morbidity and mortality, often necessitating emergent surgical intervention. While total abdominal colectomy (TAC) remains the standard of care, diverting loop ileostomy wi… |
Clinical Safety signal | Diverting loop ileostomy with antegrade colonic lavage compared with colectomy in Clostridioides difficile colitis: A decade-long propensity score-matched analysis.. Fulminant Clostridioides difficile colitis (CDC) carries high morbidity and mortality, often necessitating emergent surgical intervention. While total abdominal colectomy (TAC) remains the standard of care, diverting loop ileostomy wi… |
Clinical Selected reported efficacy | ORR 61.5% |
Clinical Reported ORR | 61.5% |
Clinical Result source | ClinicalTrials.gov NCT04620681 |
Clinical Program phase | PHASE_1 |
Clinical Trial ref | NCT04620681 |
타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Standard Therapeutic DLI (Standard Therapeutic DLI) University of Arizona·Acute Lymphoid Leukemia 16 trials |
|---|---|
Overview Program | Standard Therapeutic DLI |
Overview Company | University of Arizona |
Overview Modality | CGT |
Overview Target | Acute Lymphoid Leukemia |
Overview Indication | Acute Lymphoid Leukemia; Acute Myeloid Leukemia |
Overview Phase | PHASE_1 |
Overview Status | RECRUITING |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | Diverting loop ileostomy with antegrade colonic lavage compared with colectomy in Clostridioides difficile colitis: A decade-long propensity score-matched analysis.. Fulminant Clostridioides difficile colitis (CDC) carries high morbidity and mortality, often necessitating emergent surgical intervention. While total abdominal colectomy (TAC) remains the standard of care, diverting loop ileostomy wi… |
Clinical Safety signal | Diverting loop ileostomy with antegrade colonic lavage compared with colectomy in Clostridioides difficile colitis: A decade-long propensity score-matched analysis.. Fulminant Clostridioides difficile colitis (CDC) carries high morbidity and mortality, often necessitating emergent surgical intervention. While total abdominal colectomy (TAC) remains the standard of care, diverting loop ileostomy wi… |
Clinical Selected reported efficacy | ORR 61.5% |
Clinical Reported ORR | 61.5% |
Clinical Result source | ClinicalTrials.gov NCT04620681 |
Clinical Program phase | PHASE_1 |
Clinical Trial ref | NCT04620681 |
추천 비교
추천 비교